News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
97,001 Results
Type
Article (2388)
Company Profile (48)
Press Release (94565)
Section
Business (39884)
Career Advice (57)
Deals (6595)
Drug Delivery (3)
Drug Development (11144)
Employer Resources (15)
FDA (2028)
Job Trends (2273)
News (57468)
Policy (3307)
Tag
Academia (208)
Accelerated approval (7)
Allergies (17)
Alliances (4178)
ALS (20)
Alzheimer's disease (197)
Antibody-drug conjugate (ADC) (46)
Approvals (2140)
Artificial intelligence (37)
Autoimmune disease (18)
Automation (2)
Bankruptcy (21)
Best Places to Work (2079)
Biosimilars (18)
Biotechnology (37)
Bladder cancer (58)
Brain cancer (7)
Breast cancer (73)
Cancer (852)
Cardiovascular disease (70)
Career advice (52)
Career pathing (1)
CAR-T (18)
CDC (2)
Cell therapy (60)
Cervical cancer (9)
Clinical research (10232)
Collaboration (126)
Compensation (194)
Complete response letters (5)
COVID-19 (217)
CRISPR (7)
C-suite (52)
Cystic fibrosis (16)
Data (1202)
Depression (11)
Diabetes (114)
Diagnostics (957)
Digital health (6)
Diversity, equity & inclusion (6)
Drug discovery (16)
Drug pricing (13)
Duchenne muscular dystrophy (50)
Earnings (33882)
Editorial (3)
Employer resources (14)
Events (13247)
Executive appointments (72)
FDA (2668)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (5)
Funding (127)
Gene editing (15)
Generative AI (2)
Gene therapy (71)
GLP-1 (147)
Government (345)
Grass and pollen (3)
Guidances (258)
Healthcare (3092)
HIV (10)
Huntington's disease (10)
IgA nephropathy (14)
Immunology and inflammation (43)
Immuno-oncology (6)
Indications (18)
Infectious disease (253)
Inflammatory bowel disease (22)
Influenza (12)
Intellectual property (21)
Interviews (3)
IPO (4680)
IRA (1)
Job creations (286)
Job search strategy (48)
JPM (3)
Kidney cancer (5)
Labor market (11)
Layoffs (34)
Legal (520)
Liver cancer (9)
Lung cancer (200)
Lymphoma (114)
Machine learning (1)
Management (4)
Manufacturing (52)
MASH (22)
Medical device (2290)
Medtech (2297)
Mergers & acquisitions (2105)
Metabolic disorders (231)
Multiple sclerosis (68)
NASH (1)
Neurodegenerative disease (23)
Neuropsychiatric disorders (10)
Neuroscience (387)
NextGen: Class of 2026 (601)
Non-profit (355)
Now hiring (6)
Obesity (94)
Opinion (5)
Ovarian cancer (19)
Pain (23)
Pancreatic cancer (36)
Parkinson's disease (28)
Partnered (2)
Patents (39)
Patient recruitment (45)
Peanut (5)
People (4130)
Pharmaceutical (3)
Pharmacy benefit managers (3)
Phase 1 (2759)
Phase 2 (4357)
Phase 3 (3965)
Pipeline (1602)
Policy (10)
Postmarket research (316)
Preclinical (930)
Press Release (7)
Prostate cancer (25)
Psychedelics (3)
Radiopharmaceuticals (36)
Rare diseases (104)
Real estate (420)
Recruiting (5)
Regulatory (2993)
Reports (11)
Research institute (159)
Resumes & cover letters (6)
Rett syndrome (6)
RSV (13)
Schizophrenia (25)
Series A (13)
Series B (19)
Service/supplier (2)
Sickle cell disease (8)
Special edition (3)
Spinal muscular atrophy (18)
Startups (252)
Supply chain (8)
Tariffs (5)
The Weekly (3)
Vaccines (86)
Venture capital (9)
Weight loss (47)
Women's health (10)
Date
Today (21)
Last 7 days (86)
Last 30 days (360)
Last 365 days (5517)
2026 (547)
2025 (5597)
2024 (6266)
2023 (7231)
2022 (8354)
2021 (9320)
2020 (8718)
2019 (6586)
2018 (5091)
2017 (4742)
2016 (3671)
2015 (5290)
2014 (3415)
2013 (2300)
2012 (2605)
2011 (2633)
2010 (2303)
Location
Africa (51)
Alabama (7)
Arizona (28)
Arkansas (1)
Asia (5424)
Australia (564)
California (2326)
Canada (528)
China (212)
Colorado (69)
Connecticut (89)
Delaware (69)
Europe (11530)
Florida (305)
Georgia (55)
Idaho (11)
Illinois (109)
India (10)
Indiana (94)
Japan (72)
Kansas (14)
Kentucky (17)
Louisiana (8)
Maine (47)
Maryland (173)
Massachusetts (1644)
Michigan (39)
Minnesota (79)
Missouri (21)
Montana (6)
Nevada (9)
New Hampshire (10)
New Jersey (699)
New York (460)
North Carolina (225)
Northern California (888)
Ohio (45)
Oregon (1)
Pennsylvania (395)
Puerto Rico (1)
Rhode Island (1)
South America (94)
South Carolina (4)
Southern California (1289)
Tennessee (22)
Texas (224)
United States (7386)
Utah (65)
Virginia (14)
Washington D.C. (7)
Washington State (162)
Wisconsin (10)
97,001 Results for "85".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
QuantX Biosciences Closes Oversubscribed $85M Series B Financing
February 9, 2026
·
2 min read
Job Trends
Amidst Industry Challenges, 85% of Pharmas Increase Investment in AI
A new report found that 85% of pharma respondents are increasing their artificial intelligence investments, and 70% see AI as an immediate priority. Two experts discuss how biopharmas are implementing and adopting AI, including their increased use of external help with the process.
July 31, 2025
·
4 min read
·
Angela Gabriel
Press Releases
XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership
January 14, 2026
·
8 min read
Press Releases
Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million
January 23, 2026
·
6 min read
Press Releases
Freenome Delivers Improved Performance in Its Colorectal Cancer Blood Test with Sensitivity of 85% for CRC and 22% for Advanced Precancerous Lesions
January 6, 2026
·
3 min read
Press Releases
Curebound Awards $8.5 Million for 23 Cancer Research Studies, Including $1 Million Cure Prize
December 11, 2025
·
7 min read
Press Releases
Tenon Medical Announces Closing of $2.85 Million At-The-Market PIPE Financing
November 17, 2025
·
4 min read
Mergers & acquisitions
UPDATE: Novo Nordisk Seeks To Steal Metsera From Pfizer With $8.5B Offer
Pfizer called Novo’s offer “reckless and unprecedented,” in a statement issued Thursday morning.
October 30, 2025
·
4 min read
·
Annalee Armstrong
Deals
4DMT Sends Eye Disease Asset’s Asia Rights to Otsuka for $85M Upfront
Otsuka Pharmaceuticals could shell out over $400 million in total for the Asia-Pacific rights to 4D-150, which combines a VEGF-C inhibitory RNAi with Regeneron’s Eylea into a single ocular injection.
October 31, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Aquestive Therapeutics Announces Pricing of $85 Million Underwritten Offering of Common Stock
August 14, 2025
·
5 min read
1 of 9,701
Next
